Ftse Mib
34.276,20
-0,29%
DAX
18.502,77
-0,52%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.180,79
-2,58%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Abitare In Spa (ABT) Abitare In Spa (ABT) Notizie

ABT

Abitare In (ABT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
01/10/200919:22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketBIT:ABTAbbott Laboratories
29/09/200922:41Dow Jones NewsMARKET SNAPSHOT: U.S. Stock Market Could Bask In More M&ABIT:ABTAbbott Laboratories
29/09/200919:58Dow Jones NewsCORRECT: FOCUS: BASF, Other Chemical Cos Targeting AsiaBIT:ABTAbbott Laboratories
29/09/200919:05Dow Jones NewsFOCUS: BASF, Other Chemical Cos Targeting Asia For GrowthBIT:ABTAbbott Laboratories
29/09/200908:00Dow Jones NewsFOCUS: Solvay Plans New Life As Chemicals, Plastics PlayBIT:ABTAbbott Laboratories
28/09/200921:25Dow Jones NewsUPDATE: Abbott Continues Acquisition Streak With Solvay DealBIT:ABTAbbott Laboratories
28/09/200920:02Dow Jones NewsAbbott Continues Acquisition Streak With Solvay DealBIT:ABTAbbott Laboratories
28/09/200919:01Dow Jones NewsAbbott Looks To Solvay To Help Solve Its Humira DependenceBIT:ABTAbbott Laboratories
28/09/200916:03Dow Jones News5th UPDATE:Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashBIT:ABTAbbott Laboratories
28/09/200911:50Dow Jones NewsSolvay CEO Sees No New Acquisition Before Closing Pharma SaleBIT:ABTAbbott Laboratories
28/09/200910:39Dow Jones News4th UPDATE:Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashBIT:ABTAbbott Laboratories
28/09/200909:57Dow Jones News3rd UPDATE: Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashBIT:ABTAbbott Laboratories
28/09/200909:02Dow Jones News2nd UPDATE: Solvay Sells Pharma Unit To Abbott For EUR5.2 BillionBIT:ABTAbbott Laboratories
28/09/200908:17Dow Jones NewsUPDATE: Solvay Sells Pharma Unit To Abbott For EUR5.2 BillionBIT:ABTAbbott Laboratories
28/09/200907:41Dow Jones NewsSolvay Sells Pharma Unit To Abbott Laboratories For EUR5.2 BillionBIT:ABTAbbott Laboratories
28/09/200907:00PR Newswire (US)Abbott to Acquire Solvay Pharmaceuticals BusinessBIT:ABT
27/09/200916:58Dow Jones NewsWSJ: Abbot Close To Announcing Deal For Solvay Pharma UnitBIT:ABTAbbott Laboratories
24/09/200922:26Dow Jones NewsAbbott Labs To Pay Church & Dwight $27 Million In Patent SettlementBIT:ABTAbbott Laboratories
24/09/200922:01Dow Jones NewsCORRECT: Church & Dwight: Abbott Labs To Pay Company $27 MillionBIT:ABTAbbott Laboratories
24/09/200901:09Dow Jones News2nd UPDATE:Abbott Stent Tops Boston Sci Devices In 2 StudiesBIT:ABTAbbott Laboratories
24/09/200900:23Dow Jones NewsStudy Shows 2-Year Benefits For Stent-Guiding SystemBIT:ABTAbbott Laboratories
23/09/200923:19Dow Jones NewsUPDATE: Abbott Stent Tops Boston Sci Devices In 2 StudiesBIT:ABTAbbott Laboratories
23/09/200921:35Dow Jones NewsWSJ: Abbott Bids For Solvay Drug Unit - SourcesBIT:ABTAbbott Laboratories
23/09/200921:13Dow Jones NewsAbbott Heart Stent Tops Newer Boston Sci Device In StudyBIT:ABTAbbott Laboratories
23/09/200920:40Dow Jones NewsAbbott Stent Tops Older Boston Scientific Device In Big StudyBIT:ABTAbbott Laboratories
21/09/200921:37Dow Jones News2nd UPDATE: Abbott, Medtronic: Stents Perform Well At 3 YearsBIT:ABTAbbott Laboratories
21/09/200919:25Dow Jones NewsUPDATE: Abbott, Medtronic Say Stents Perform Well At 3 YearsBIT:ABTAbbott Laboratories
21/09/200917:31Dow Jones NewsAbbott, Medtronic: Heart Stents Top Rival In 3-Year Study DataBIT:ABTAbbott Laboratories
21/09/200917:00PR Newswire (US)Abbott's XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results inBIT:ABT
21/09/200915:03PR Newswire (US)Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2BIT:ABT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT

La tua Cronologia

NASDAQ
ADI
Analog Devices
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network